{
  "meta": {
    "title": "279_Obstetrics_Gynecology_Neet_2021",
    "url": "https://brainandscalpel.vercel.app/279-obstetrics-gynecology-neet-2021-6f1f3b98.html",
    "scrapedAt": "2025-11-30T12:57:45.973Z"
  },
  "questions": [
    {
      "text": "A pregnant woman at 36 weeks of gestation with a prosthetic valve replacement for mitral stenosis is on warfarin therapy. Her INR is 3. What is the appropriate next step in management?<div class='question-desc-html'><p>LMWH- Low molecular weight heparin</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Stop warfarin and start LMWH"
        },
        {
          "id": 2,
          "text": "Stop warfarin and start heparin"
        },
        {
          "id": 3,
          "text": "Continue warfarin"
        },
        {
          "id": 4,
          "text": "Stop warfarin, start LMWH and asprin"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The next appropriate step in the management of a pregnant woman with a prosthetic valve on warfarin therapy at 36 weeks of gestation is to <strong>stop warfarin and start low molecular weight heparin (LMWH).&nbsp;</strong></p>\n<p><strong>Warfarin</strong> is <strong>safe</strong> and effective in preventing thromboembolism in the mother during the <strong>2nd trimester</strong>. However, it is<strong> teratogenic</strong> and can lead to&nbsp;miscarriage, stillbirths, fetal anticoagulation, and fetal embryopathy if used in the <strong>1st trimester</strong>.</p>\n<p>Heparin is safe for the fetus as it does not cross the placenta but is less effective than warfarin in preventing thromboembolism.</p>\n<div class=\"page\" title=\"Page 970\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 970\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 970\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<table>\n<tbody>\n<tr>\n<td><strong>Period of gestation</strong></td>\n<td><strong>Anticoagulant</strong></td>\n</tr>\n<tr>\n<td>\n<p>Till 12 completed weeks</p>\n</td>\n<td>LMWH or UFH</td>\n</tr>\n<tr>\n<td>13 to 36 weeks</td>\n<td>Warfarin</td>\n</tr>\n<tr>\n<td>36 weeks till just before delivery</td>\n<td>LMWH or UFH</td>\n</tr>\n<tr>\n<td>6 hours after vaginal delivery and 24 hours after cesarean section</td>\n<td>Warfarin, LMWH or UFH&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>LMWH- Low molecular weight heparin, UFH- Unfractionated heparin&nbsp;</p>\n<p>For patients taking LMWH,<strong> factor Xa</strong> levels should be monitored <strong>weekly</strong>.</p>\n<p>Heparin should be discontinued just before (<strong>at least 6 hours before</strong>) delivery. If delivery occurs before discontinuation and there is extensive bleed&shy;ing, then<strong> iv protamine sulfate</strong> can be given. Warfarin or heparin anticoagulation can be <strong>restarted after 6 hours</strong> of vaginal delivery, usually without any problem.</p>\n<div class=\"page\" title=\"Page 970\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 970\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 970\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Warfarin, LMWH, and UFH <strong>do not accumulate in breast milk</strong> and do not have an anticoagulant effect in the newborn. They are <strong>compatible with</strong> <strong>breastfeeding.</strong></p>\n<p>Other options:</p>\n<p>Option B: Unfractionated heparin can also be given instead of LMWH. However, in this case, the better answer is to give LMWH; because, in clinical practice, LMWHs have a long half-life, once-daily dosing, and fewer side effects. If LMWH is unavailable or cost-prohibitive, or if anti-Xa levels cannot be monitored, continuous infusion of UFH can be used as an alternative to LMWH.</p>\n<p>Option D: Aspirin 75-100 mg can be given daily during pregnancy. It can be continued in women with mechanical heart valves if needed for other indications.</p>\n<p>&nbsp;</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1225",
      "difficulty": "medium"
    },
    {
      "text": "A 27-year-old female patient was found to have uterus didelphys. Which of the following is not likely to be a complication of this uterine anomaly?",
      "choices": [
        {
          "id": 1,
          "text": "Abortion"
        },
        {
          "id": 2,
          "text": "Endometriosis"
        },
        {
          "id": 3,
          "text": "Preterm labor"
        },
        {
          "id": 4,
          "text": "Transverse lie"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Among the given options, transverse lie is not a likely complication of uterus didelphys. A transverse lie is more likely to be seen with an arcuate or sub-septate uterus.</p>\n<p>A <strong>uterus didelphys</strong> is a Mullerian defect characterized by two separate uterine horns, each with an endometrial cavity and uterine cervix. It occurs due to the <strong>failure of fusion</strong> of the M&uuml;llerian ducts.</p>\n<p>It is usually asymptomatic but can rarely present with dyspareunia, dysmenorrhea, hematocolpos, and hematometra. Rarely, <strong>endometriosis&nbsp;</strong>(option B) and genital neoplasms may be associated with uterus didelphys.</p>\n<p>Pregnancy is possible with uterus didelphys, however, there is an increased risk of the following complications:</p>\n<ul>\n<li><strong>Spontaneous abortion&nbsp;</strong>(option A)</li>\n<li><strong>Preterm labor&nbsp;</strong>(option C)</li>\n<li><strong>Breech presentation</strong></li>\n<li>Cesarean delivery</li>\n<li>Intrauterine growth restriction</li>\n<li>Low birth weight (&lt;2.5kg)</li>\n<li>Perinatal death</li>\n</ul>\n<p>Uterus didelphys can be diagnosed with ultrasound or hysterosalpingography, but <strong>MRI</strong> provides the most accurate diagnosis.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/eae97069bece48a7b9453abd9b97eadbx608x362.PNG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Mullerian Anomalies</h3><div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p class=\"ng-binding\">&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Class</strong></td>\n<td><strong>Mullerian anomaly</strong></td>\n<td><strong>Reason/Feature</strong></td>\n<td><strong>Treatment</strong></td>\n<td><strong>Complications</strong></td>\n</tr>\n<tr>\n<td>I</td>\n<td><strong>Uterine hypoplasia or uterine agenesis</strong></td>\n<td>Underdeveloped or non-developed paramesonephric duct</td>\n<td>\n<ul>\n<li>Infertility treatment -surrogacy&nbsp;</li>\n<li>Vaginoplasty for vaginal hypoplasia</li>\n</ul>\n</td>\n<td>Infertility\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>II</td>\n<td><strong>Unicornuate uterus</strong></td>\n<td>Non-developed paramesonephric duct</td>\n<td>Excision of&nbsp;rudimentary horn, if any &nbsp;</td>\n<td>\n<ul>\n<li>Uterine rupture</li>\n<li>Abortions</li>\n<li>Risk of miscarriage,</li>\n<li>Malpresentation&nbsp;</li>\n<li>Preterm delivery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>III</td>\n<td><strong>Uterus didelphys</strong></td>\n<td>Unfused paramesonephric duct</td>\n<td>\n<p>Metroplasty- Resection of membrane and fundal recombination. This can be:</p>\n<ul>\n<li>Hysteroscopic</li>\n<li>Open e.g., Strassman metroplasty</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Risk of miscarriage,</li>\n<li>Malpresentation&nbsp;</li>\n<li>Preterm delivery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>IV</td>\n<td><strong>Bicornuate uterus&nbsp;</strong></td>\n<td>Lower part is fused whereas upper part is unfused</td>\n<td>Metroplasty in selected cases&nbsp;</td>\n<td>\n<ul>\n<li>Risk of miscarriage,</li>\n<li>Malpresentation&nbsp;</li>\n<li>Preterm delivery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>V</td>\n<td><strong>Septate uterus&nbsp;</strong></td>\n<td>Septa of fused part persists</td>\n<td>Hysteroscopic septal resection&nbsp;</td>\n<td>\n<ul>\n<li>Infertility</li>\n<li>Risk of miscarriage,</li>\n<li>Malpresentation&nbsp;</li>\n<li>Preterm delivery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>VI</td>\n<td><strong>Arcuate uterus</strong></td>\n<td>A small indentation at upper part</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>VII</td>\n<td><strong>Diethylstillbesterone (DES), drug related</strong></td>\n<td>T-shaped uterus, shortened and narrow fallopian tubes, cervical collars (Cockscomb cervix)</td>\n<td>&nbsp;</td>\n<td>\n<ul>\n<li>Ectopic pregnancy</li>\n<li>Cervical incompetence</li>\n<li>Clear cell adenocarcinoma of cervix and vagina</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>A common complication is an abortion in the second trimester.</p>\n<p>Arcuate uterus: Some studies report no increase in adverse outcomes, whereas some studies have shown excessive second trimester loss, preterm labor and malpresentations.</p>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b5daabaa46584f8ca9566b45a6d7c54dx1280x4923.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1215",
      "difficulty": "medium"
    },
    {
      "text": "A woman who underwent dilatation and curettage for molar pregnancy 6 months ago presents with persistent symptoms of abdominal pain and distention. On further evaluation, the beta-hCG levels were persistently elevated and cannonball foci were found on the chest X-ray. What is the appropriate management in this case?",
      "choices": [
        {
          "id": 1,
          "text": "Methotrexate with folinic acid"
        },
        {
          "id": 2,
          "text": "Methotrexate"
        },
        {
          "id": 3,
          "text": "EMACO regimen"
        },
        {
          "id": 4,
          "text": "Hysterectomy"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario of a woman with a past history of <strong>D(&amp;)C</strong> for <strong>molar pregnancy</strong>, now presenting with <strong>abdominal pain</strong> and <strong>distension</strong>, <strong>elevated beta-HCG levels</strong>, and <strong>cannonball metastasis to the lung</strong> is suggestive of gestational trophoblastic neoplasia (GTN).</p>\n<p>The next step is to categorize the patient as low/high risk based on the WHO prognostic scoring system to decide the treatment modality.&nbsp;</p>\n<p>WHO Prognostic Scoring System, adapted by FIGO:</p>\n<table>\n<tbody>\n<tr>\n<td rowspan=\"2\">&nbsp;<strong>Prognostic Factor</strong></td>\n<td colspan=\"4\"><strong>Score</strong></td>\n</tr>\n<tr>\n<td>0</td>\n<td>1</td>\n<td>2</td>\n<td>4</td>\n</tr>\n<tr>\n<td>Age</td>\n<td>&lt; 40</td>\n<td>&nbsp;&gt;40</td>\n<td>-</td>\n<td>-</td>\n</tr>\n<tr>\n<td>Antecedent gestation</td>\n<td>Mole</td>\n<td>Abortion</td>\n<td>Term</td>\n<td>-</td>\n</tr>\n<tr>\n<td>Interval in months</td>\n<td>&lt;4</td>\n<td>4-6</td>\n<td>7-12</td>\n<td>&gt;12</td>\n</tr>\n<tr>\n<td>Pretreatment serum hCG (IU/L)</td>\n<td>&lt; 10<sup>3</sup></td>\n<td>10<sup>3</sup>&nbsp;to &lt; 10<sup>4</sup></td>\n<td>10<sup>4</sup>&nbsp;to &lt; 10<sup>5</sup></td>\n<td>&gt; 10<sup>5</sup></td>\n</tr>\n<tr>\n<td>Largest tumor size (including the uterus)</td>\n<td>&lt;3</td>\n<td>3-4</td>\n<td>&ge; 5</td>\n<td>&nbsp;-</td>\n</tr>\n<tr>\n<td>Site of metastases</td>\n<td>Lung</td>\n<td>Spleen, kidney</td>\n<td>GI tract</td>\n<td>Brain, liver</td>\n</tr>\n<tr>\n<td>Number of metastases</td>\n<td>-</td>\n<td>1-4</td>\n<td>5-8</td>\n<td>&gt;8</td>\n</tr>\n<tr>\n<td>Previously failed chemotherapy</td>\n<td>&nbsp;-</td>\n<td>-</td>\n<td>single drug</td>\n<td>&ge; 2 drugs</td>\n</tr>\n<tr>\n<td colspan=\"5\">\n<ul>\n<li><strong>Low-risk GTN: score &le;6</strong></li>\n<li><strong>High-risk GTN: score &ge;7</strong></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Based on the available clinical information,</p>\n<ul>\n<li>Antecedent gestation: molar pregnancy, score= 0</li>\n<li>Interval: 6 months, score= 1</li>\n<li>Site of metastasis: lung, score= 0</li>\n</ul>\n<p>The total score is <strong>1</strong>, hence it is a case of <strong>low-risk GTN</strong>&nbsp;and the management involves treatment with <strong>methotrexate with folinic acid.</strong></p>\n<p>Treatment of GTN:</p>\n<p><strong>Low-risk GTN (FIGO Stages I-III: score &lt;7):&nbsp;</strong>Single-agent chemotherapy with&nbsp;<strong>methotrexate (MTX)&nbsp;</strong>or dactinomycin (less commonly used).&nbsp;</p>\n<ul>\n<li><strong>50&nbsp;mg MTX</strong>&nbsp;is given IM on days 1, 3, 5, and 7 with&nbsp;<strong>folinic acid</strong>&nbsp;on alternate days.</li>\n</ul>\n<p><strong>High-risk GTN</strong>&nbsp;<strong>(FIGO Stages II-III: score &gt;7 and Stage IV)</strong>: Multiple agent chemotherapies, with or without adjuvant surgery or radiotherapy. The preferred multiple-agent chemotherapy regime is the&nbsp;<strong>EMACO regime</strong>:</p>\n<ul>\n<li>Etoposide</li>\n<li>Methotrexate</li>\n<li>Dactinomycin (actinomycin D)</li>\n<li>Cyclophosphamide</li>\n<li>Vincristine (Oncovin)</li>\n</ul>\n<p>The FIGO Anatomic Staging of GTN is shown in the image below:</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3116c609600d414c8f967c1c71405d32x1280x2318.JPEG\" alt=\"Explanation Image\"><p>GTN typically develops along with or after a molar pregnancy. Rarely, it may develop after live birth, miscarriage, or medical termination of pregnancy. &nbsp;</p>\n<p>The given image below shows the classification of gestational trophoblastic diseases:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c4c9b153f34c4d858d5955d3df3acfd5x1280x1460.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Risk factors and FIGO staging of Gestational trophoblastic neoplasia</h3><p><strong>Risk factors</strong></p>\n<ul>\n<li>Older age</li>\n<li>&beta;-hCG levels &gt; 100,000 mIU/mL</li>\n<li>Uterine size that is large-forgestational age</li>\n<li>Theca-lutein cysts &gt; 6 cm</li>\n<li>Slow decline in &beta;-hCG levels</li>\n<li>Postevacuation uterine sonographic surveillance showing myometrial nodules or hypervascularity may be a predictor of subsequent neoplasia.</li>\n</ul>\n<p>FIGO staging:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Stage I</strong></td>\n<td><strong>Disease</strong> <strong>confined to the uterus</strong></td>\n</tr>\n<tr>\n<td><strong>Stage II</strong></td>\n<td>GTD extends <strong>outside of the uterus but is limited to the genital structure</strong></td>\n</tr>\n<tr>\n<td><strong>Stage III</strong></td>\n<td><strong>Lung metastasis</strong> with or without genital tract involvement</td>\n</tr>\n<tr>\n<td><strong>Stage IV</strong></td>\n<td><strong>Other metastasis</strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1212",
      "difficulty": "medium"
    },
    {
      "text": "A female patient has a history of three miscarriages. Identify the investigation that was done from the image shown below.",
      "choices": [
        {
          "id": 1,
          "text": "Hysteroscopy"
        },
        {
          "id": 2,
          "text": "Saline infusion sonography"
        },
        {
          "id": 3,
          "text": "Hysterosalpingography"
        },
        {
          "id": 4,
          "text": "Transvaginal ultrasonography"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The investigation shown in the given image is <strong>hysterosalpingography.&nbsp;</strong>The given hysterosalpingogram shows a<strong> unicornuate uterus</strong>.</p>\n<p>Hysterosalpingography (HSG) is an imaging modality in which radiopaque contrast is injected through the cervical canal to assess the endometrial cavity, the fallopian tubes, and the endocervical canal.</p>\n<p>HSG should be done between<strong> days 5 and 10 of the menstrual cycle</strong>, in the <strong>preovulatory phase,&nbsp;</strong>as an outpatient procedure. <strong>Leech</strong> <strong>Wilkinson cannula</strong>, <strong>Rubin's cannula,</strong> or <strong>Foley's catheter no.14</strong> is introduced into the endometrial cavity through the cervical os, and the contrast is injected. The uterine cavity and fallopian tubes are then visualized and X-rays are obtained.</p>\n<p>HSG can be used for the following:</p>\n<ul>\n<li>To assess tubal patency in infertility&nbsp;</li>\n<li>To detect uterine anomalies,&nbsp;synechiae, and polyps</li>\n<li>To detect incompetence of the cervical os</li>\n</ul>\n<p>Contraindications to HSG:</p>\n<div class=\"page\" title=\"Page 66\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>Acute pelvic infection&nbsp;</li>\n<li>Active uterine bleeding</li>\n<li>Pregnancy/ suspected pregnancy</li>\n<li>Contrast allergy</li>\n<li>Premenstrual phase</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n<p>HSG is a safe procedure, however, complications such as ascending spread of infection, chemical peritonitis, allergic reaction to the dye, or pelvic endometriosis may occur.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9fefe6552b774a7bb4f076d53f75132ex1280x796.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a8fe7b4e3f674d409ef0cdfd4aaa9f18x600x468.JPEG\" alt=\"Explanation Image\"><p>Other options:</p>\n<p>Option A: Hysteroscopy is an operative procedure in which the uterine cavity can be visualized by passing a <strong>fiberoptic telescope via the cervix</strong>. It can be <strong>diagnostic</strong> or <strong>therapeutic</strong>. A hysteroscopic image of a uterus with carcinoma is shown below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/56e8bad84a6e4253b74ca4bf3c8acdcfx512x469.PNG\" alt=\"Explanation Image\"><p>Option B:&nbsp;Saline infusion sonography is a procedure where <strong>normal saline is injected into the uterine cavity</strong> and the uterus is imaged with <strong>transvaginal sonography</strong>. It is shown in the image below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ad042dbd49d24626991ea7fe1b16d2a1x625x481.JPEG\" alt=\"Explanation Image\"><p>Option D:&nbsp;Transvaginal ultrasonography is a noninvasive imaging technique using the transvaginal approach. It provides a more detailed evaluation of the pelvic organs as compared to the transabdominal approach.</p><hr><h3>Related Pearl: Mullerian Anomalies</h3><div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p class=\"ng-binding\">&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Class</strong></td>\n<td><strong>Mullerian anomaly</strong></td>\n<td><strong>Reason/Feature</strong></td>\n<td><strong>Treatment</strong></td>\n<td><strong>Complications</strong></td>\n</tr>\n<tr>\n<td>I</td>\n<td><strong>Uterine hypoplasia or uterine agenesis</strong></td>\n<td>Underdeveloped or non-developed paramesonephric duct</td>\n<td>\n<ul>\n<li>Infertility treatment -surrogacy&nbsp;</li>\n<li>Vaginoplasty for vaginal hypoplasia</li>\n</ul>\n</td>\n<td>Infertility\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>II</td>\n<td><strong>Unicornuate uterus</strong></td>\n<td>Non-developed paramesonephric duct</td>\n<td>Excision of&nbsp;rudimentary horn, if any &nbsp;</td>\n<td>\n<ul>\n<li>Uterine rupture</li>\n<li>Abortions</li>\n<li>Risk of miscarriage,</li>\n<li>Malpresentation&nbsp;</li>\n<li>Preterm delivery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>III</td>\n<td><strong>Uterus didelphys</strong></td>\n<td>Unfused paramesonephric duct</td>\n<td>\n<p>Metroplasty- Resection of membrane and fundal recombination. This can be:</p>\n<ul>\n<li>Hysteroscopic</li>\n<li>Open e.g., Strassman metroplasty</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Risk of miscarriage,</li>\n<li>Malpresentation&nbsp;</li>\n<li>Preterm delivery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>IV</td>\n<td><strong>Bicornuate uterus&nbsp;</strong></td>\n<td>Lower part is fused whereas upper part is unfused</td>\n<td>Metroplasty in selected cases&nbsp;</td>\n<td>\n<ul>\n<li>Risk of miscarriage,</li>\n<li>Malpresentation&nbsp;</li>\n<li>Preterm delivery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>V</td>\n<td><strong>Septate uterus&nbsp;</strong></td>\n<td>Septa of fused part persists</td>\n<td>Hysteroscopic septal resection&nbsp;</td>\n<td>\n<ul>\n<li>Infertility</li>\n<li>Risk of miscarriage,</li>\n<li>Malpresentation&nbsp;</li>\n<li>Preterm delivery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>VI</td>\n<td><strong>Arcuate uterus</strong></td>\n<td>A small indentation at upper part</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>VII</td>\n<td><strong>Diethylstillbesterone (DES), drug related</strong></td>\n<td>T-shaped uterus, shortened and narrow fallopian tubes, cervical collars (Cockscomb cervix)</td>\n<td>&nbsp;</td>\n<td>\n<ul>\n<li>Ectopic pregnancy</li>\n<li>Cervical incompetence</li>\n<li>Clear cell adenocarcinoma of cervix and vagina</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>A common complication is an abortion in the second trimester.</p>\n<p>Arcuate uterus: Some studies report no increase in adverse outcomes, whereas some studies have shown excessive second trimester loss, preterm labor and malpresentations.</p>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b5daabaa46584f8ca9566b45a6d7c54dx1280x4923.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/667127b0407c41328f4845a1538fb093.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1220",
      "difficulty": "easy"
    },
    {
      "text": "A 56-year-old multipara woman presented with grade II/III uterine prolapse with cystocele. She complains of passing urine on coughing and sneezing. What is the type of urinary incontinence seen in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Overflow incontinence"
        },
        {
          "id": 2,
          "text": "Urge incontinence"
        },
        {
          "id": 3,
          "text": "Stress incontinence"
        },
        {
          "id": 4,
          "text": "Neurogenic bladder"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The type of urinary incontinence present in a patient with prolapse and cystocele experiencing <strong>urination on coughing </strong>and<strong> sneezing</strong> is <strong>stress incontinence</strong>.</p>\n<div class=\"page\" title=\"Page 238\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Stress incontinence refers to the<strong> involuntary leakage of urine</strong> when there is <strong>increased intra-abdominal pressure</strong> (eg, coughing, sneezing, laughing, Valsalva maneuver). <strong>Absence of detrusor muscle contraction </strong>is seen in urodynamic studies.</p>\n<p>Causes:</p>\n<ul>\n<li>Age and menopause - due to estrogen deficiency</li>\n<li>Multiparity - due to loss of pelvic muscle tone</li>\n<li>Obesity</li>\n<li>Smoking</li>\n<li>Constipation, chronic cough</li>\n<li>Pelvic organ prolapse</li>\n<li>Pregnancy - due to the effect of <strong>progesterone</strong> and pressure of the gravid uterus on the bladder neck.</li>\n<li>Puerperium - due to descent of the bladder neck, loss of urethro-vesical angle, and reduced pelvic muscle tone&nbsp;</li>\n<li>Surgical repair of vesicovaginal fistula</li>\n</ul>\n<div class=\"page\" title=\"Page 239\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Grading of genuine stress incontinence (GSI) :</p>\n<ul>\n<li>Grade I: Incontinence with only severe stress, such as coughing, sneezing, and jogging.</li>\n<li>Grade II: Incontinence with moderate stress, such as fast walk, going up and down the stairs.</li>\n<li>Grade III: Incontinence with mild stress such as standing.</li>\n</ul>\n<p>Investigations are <strong>only done prior to surgery</strong> to confirm the diagnosis. They include:</p>\n<ul>\n<li>Stress test</li>\n<li>Cotton swab or Q-tip test</li>\n<li>Marshall and Bonney&rsquo;s test</li>\n<li>Urethroscopy</li>\n<li>Urodynamic studies.</li>\n</ul>\n<p>These are not required prior to conservative management.</p>\n<p>Conservative management includes Kegel's pelvic exercises, electric nerve stimulation, devices like pessaries, vaginal cones, and artificial sphincters. Medical treatment with estrogen creams, alpha agonists, venlafaxine, and imipramine may be useful.</p>\n<p>Other options:</p>\n<p>Option A:<strong> Overflow incontinence</strong> is an old term that refers to the <strong>inability to empty the bladder</strong>, with involuntary, continuous urinary dribbling. Currently, it refers to another presentation of urge incontinence.&nbsp;</p>\n<p>Option B: <strong>Urge incontinence</strong> is the involuntary escape of urine when there is an imminent need to urinate. It occurs due to <strong>detrusor muscle overactivity</strong> or <strong>detrusor instability</strong>. It is seen more commonly in <strong>old women with decreased bladder capacity</strong>, decreased sensation, and CNS inhibition.&nbsp;</p>\n<p>Option D: <strong>Neurogenic bladder</strong> occurs in patients with neurogenic dysfunction leading to detrusor hyperreflexia. Conditions such as multiple sclerosis, stroke, Parkinson's disease, and spinal injury give rise to this. They present with urgency or urge incontinence.</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1208",
      "difficulty": "easy"
    },
    {
      "text": "A 32-year-old married woman who came for the evaluation of infertility was found to have a septum in her uterine cavity. What would be the appropriate management of this case?",
      "choices": [
        {
          "id": 1,
          "text": "Hysterectomy"
        },
        {
          "id": 2,
          "text": "Laparoscopy and metroplasty"
        },
        {
          "id": 3,
          "text": "Hysteroscopy and septoplasty"
        },
        {
          "id": 4,
          "text": "Laparotomy and metroplasty"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The appropriate management for a 32-year-old woman with a <strong>septate uterus</strong>&nbsp;is <strong>hysteroscopy </strong>and<strong> septoplasty</strong>.</p>\n<p>Hysteroscopic septoplasty refers to the resection of the uterine septum under&nbsp;<strong>hysteroscopic</strong>&nbsp;guidance. The septum can be resected either with a resectoscope or a laser.&nbsp;It does not scar the uterus and avoids the necessity of cesarean sections for future pregnancies. There is a reduced risk of pelvic adhesions, compared with transabdominal approaches.</p>\n<p>A&nbsp;<strong>septate uterus</strong>&nbsp;is characterized by a&nbsp;<strong>septum in the endometrial cavity</strong>.&nbsp;It is caused by the failure of the medial segments of the M&uuml;llerian ducts to regress. This creates a permanent septum within the uterine cavity.&nbsp;</p>\n<p>The septum can project partially from the fundus or extend completely to the cervical os. It is the <strong>most common&nbsp;congenital uterine malformation</strong> in women with infertility.</p>\n<p>Other options:</p>\n<p>Option A:&nbsp;<strong>Hysterectomy</strong> is not advisable since the patient has come for infertility evaluation and desires pregnancy.</p>\n<p>Options B &amp; D:<strong> Laparoscopy/laparotomy and metroplasty&nbsp;</strong>are not preferred for the treatment of a septate uterus due to the following:</p>\n<ul>\n<li>Requirement of cesarean section for subsequent pregnancies to prevent uterine rupture.</li>\n<li>Postoperative pelvic adhesions leading to infertility.</li>\n</ul>\n<div class=\"page\" title=\"Page 449\">Note: Jone's and Tompkin's metroplasties are surgeries for the septate uterus that involve a transabdominal approach. They cause uterine scarring and are hence not preferred.&nbsp;</div><hr><h3>Related Pearl: Mullerian Anomalies</h3><div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p class=\"ng-binding\">&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Class</strong></td>\n<td><strong>Mullerian anomaly</strong></td>\n<td><strong>Reason/Feature</strong></td>\n<td><strong>Treatment</strong></td>\n<td><strong>Complications</strong></td>\n</tr>\n<tr>\n<td>I</td>\n<td><strong>Uterine hypoplasia or uterine agenesis</strong></td>\n<td>Underdeveloped or non-developed paramesonephric duct</td>\n<td>\n<ul>\n<li>Infertility treatment -surrogacy&nbsp;</li>\n<li>Vaginoplasty for vaginal hypoplasia</li>\n</ul>\n</td>\n<td>Infertility\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>II</td>\n<td><strong>Unicornuate uterus</strong></td>\n<td>Non-developed paramesonephric duct</td>\n<td>Excision of&nbsp;rudimentary horn, if any &nbsp;</td>\n<td>\n<ul>\n<li>Uterine rupture</li>\n<li>Abortions</li>\n<li>Risk of miscarriage,</li>\n<li>Malpresentation&nbsp;</li>\n<li>Preterm delivery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>III</td>\n<td><strong>Uterus didelphys</strong></td>\n<td>Unfused paramesonephric duct</td>\n<td>\n<p>Metroplasty- Resection of membrane and fundal recombination. This can be:</p>\n<ul>\n<li>Hysteroscopic</li>\n<li>Open e.g., Strassman metroplasty</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Risk of miscarriage,</li>\n<li>Malpresentation&nbsp;</li>\n<li>Preterm delivery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>IV</td>\n<td><strong>Bicornuate uterus&nbsp;</strong></td>\n<td>Lower part is fused whereas upper part is unfused</td>\n<td>Metroplasty in selected cases&nbsp;</td>\n<td>\n<ul>\n<li>Risk of miscarriage,</li>\n<li>Malpresentation&nbsp;</li>\n<li>Preterm delivery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>V</td>\n<td><strong>Septate uterus&nbsp;</strong></td>\n<td>Septa of fused part persists</td>\n<td>Hysteroscopic septal resection&nbsp;</td>\n<td>\n<ul>\n<li>Infertility</li>\n<li>Risk of miscarriage,</li>\n<li>Malpresentation&nbsp;</li>\n<li>Preterm delivery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>VI</td>\n<td><strong>Arcuate uterus</strong></td>\n<td>A small indentation at upper part</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>VII</td>\n<td><strong>Diethylstillbesterone (DES), drug related</strong></td>\n<td>T-shaped uterus, shortened and narrow fallopian tubes, cervical collars (Cockscomb cervix)</td>\n<td>&nbsp;</td>\n<td>\n<ul>\n<li>Ectopic pregnancy</li>\n<li>Cervical incompetence</li>\n<li>Clear cell adenocarcinoma of cervix and vagina</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>A common complication is an abortion in the second trimester.</p>\n<p>Arcuate uterus: Some studies report no increase in adverse outcomes, whereas some studies have shown excessive second trimester loss, preterm labor and malpresentations.</p>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b5daabaa46584f8ca9566b45a6d7c54dx1280x4923.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1218",
      "difficulty": "easy"
    },
    {
      "text": "A 30-year-old G4A3 woman had a history of miscarriage at 8 weeks, the second miscarriage at 11 weeks with no cardiac activity, and the third pregnancy loss at 24 weeks with preterm delivery due to early-onset preeclampsia. What is the most probable diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Syphilis"
        },
        {
          "id": 2,
          "text": "Antiphospholipid antibody syndrome"
        },
        {
          "id": 3,
          "text": "TORCH infections"
        },
        {
          "id": 4,
          "text": "Gestational diabetes mellitus"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario of a G4A3 woman with miscarriages at 8 and 11 weeks, and preterm delivery due to preeclampsia at 24 weeks is suggestive of <strong>antiphospholipid antibody (APLA) syndrome. </strong></p>\n<p>APLA is an autoimmune disorder commonly associated with <strong>fetal death</strong>, <strong>preterm delivery</strong>, <strong>early-onset preeclampsia</strong>, and fetal growth restriction due to placental insufficiency and thromboses. Pregnancy loss usually occurs <strong>before 10 weeks</strong>.</p>\n<p>Diagnosis of APLA requires at least <strong>1 clinical </strong>criterion and <strong>1 laboratory</strong> criterion.</p>\n<ul>\n<li>Obstetric criteria\n<ul>\n<li>One or more unexplained deaths of a morphologically normal fetus at or beyond 10 weeks or</li>\n<li>Severe preeclampsia or placental insufficiency requiring delivery before 34 weeks, or</li>\n<li>Three or more unexplained consecutive spontaneous abortions before 10 weeks</li>\n</ul>\n</li>\n<li>Laboratory criteria\n<ul>\n<li>Presence of lupus anticoagulant, or</li>\n<li>Anticardiolipin antibodies, or</li>\n<li>Anti-β2 glycoprotein antibody</li>\n</ul>\n</li>\n</ul>\n<p><strong>Recurrent pregnancy loss</strong> (RPL), also referred to as a recurrent miscarriage or habitual abortion, is historically defined as <strong>3 consecutive</strong> pregnancy losses <strong>prior to 20 weeks</strong> from the last menstrual period. </p>\n<p>Common causes include:</p>\n<ul>\n<li>Parental chromosomal abnormalities</li>\n<li>Untreated hypothyroidism</li>\n<li>Uncontrolled diabetes mellitus</li>\n<li>Uterine anatomic abnormalities,</li>\n<li>Antiphospholipid antibody syndrome </li>\n</ul>\n<p>Other options:</p>\n<p><span>Option A:</span> There is<strong> no history</strong> of <strong>STD</strong> or <strong>skin lesions </strong>suggestive of syphilis and according to<strong> Kassawitz rule</strong>, in women with untreated syphilis having a series of pregnancies, the likelihood of fetal infection in later pregnancies becomes less; usually, only the first pregnancy is an abortion, the following pregnancy losses will be stillbirths in the next trimester rather than recurrent pregnancy loss.</p>\n<p><span>Option C</span><strong>: TORCH</strong> infections may play a role in sporadic spontaneous pregnancy loss, rather than recurrent pregnancy losses.</p>\n<p><span>Option D</span>: Gestational diabetes mellitus (GDM) refers to the onset or first recognition of diabetes during pregnancy, usually at the 24-28 weeks screening test. Women with <strong>uncontrolled</strong> <strong>overt or pregestational diabetes</strong> with elevated HbA1c or prepran­dial glucose in the first trimester have an increased risk for early miscarriage, but there is a history or lab findings suggestive of gestational diabetes mellitus.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1266",
      "difficulty": "medium"
    },
    {
      "text": "A 26-year-old female patient came with a history of fatiguability and constipation for the past 1 year. She has a history of multiple blood transfusions after delivery 4 years ago. She has had a lactational failure and never regained her periods after the delivery. What is the most probable diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Sheehan syndrome"
        },
        {
          "id": 2,
          "text": "Hypothyroidism"
        },
        {
          "id": 3,
          "text": "Premature ovarian failure"
        },
        {
          "id": 4,
          "text": "Delayed blood transfusion reaction"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The most likely diagnosis in a woman with <strong>lactational failure</strong> and <strong>postpartum amenorrhea,</strong> now presenting with fatiguability and constipation is <strong>Sheehan syndrome.&nbsp;</strong>A history of multiple blood transfusions after delivery indicates major obstetric blood loss, which resulted in pituitary ischemia leading to this condition.</p>\n<p>Sheehan syndrome is&nbsp;<strong>panhypopituitarism </strong>due to<strong>&nbsp;</strong>pituitary ischemia and necrosis following massive obstetrical hemorrhage.</p>\n<p>The most severe form presents with <strong>shock</strong> due to <strong>pituitary apoplexy</strong>. It is characterized by a sudden onset headache, nausea, visual deficits, and hormonal dysfunction due to acute pituitary hemorrhage or infarction. Less severe forms present with <strong>anovulation</strong> and <strong>amenorrhea</strong>.</p>\n<p>Damage to specific pituitary cell types leads to <strong>lactational failure</strong>, loss of axillary and pubic hair, and symptoms of hypothyroidism or adrenal insufficiency. <strong>Prolactin</strong> deficiency is <strong>most commonly encountered</strong>, but <strong>adrenal insufficiency</strong> is the most <strong>life-threatening</strong> complication. Hence, the adrenal function should be immediately assessed if there is any suspicion of Sheehan syndrome.</p>\n<div class=\"page\" title=\"Page 1148\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Option B: <strong>Hypothyroidism</strong> can present with vague symptoms such as fatigue, constipation, and amenorrhea. However, postpartum hypothyroidism usually presents<strong> 4-8 months after delivery</strong> after a thyrotoxic phase with palpitations and thyroid enlargement.</p>\n<p>Option C:&nbsp;<strong>Premature ovarian failure</strong> presents with menopausal symptoms. It is due to primary ovarian dysfunction. It is diagnosed when serum FSH levels are <strong>&gt;30-40 mIU/mL on two occasions, at least one month apart.</strong></p>\n<p>Option D: Delayed transfusion reaction presents <strong>days to weeks after the transfusion</strong>. It may be asymptomatic or with low-grade fever. Coombs test may be positive, unconjugated bilirubin increased, and the rise in hemoglobin levels following the transfusion will be less than expected.</p>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1254",
      "difficulty": "easy"
    },
    {
      "text": "The ultrasound of a young woman with infertility is suggestive of a uterine anomaly. Which of the following is used to confirm the diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Hysterosalpingography"
        },
        {
          "id": 2,
          "text": "Hysteroscopy + laparoscopy"
        },
        {
          "id": 3,
          "text": "Laparoscopy"
        },
        {
          "id": 4,
          "text": "Transvaginal sonography"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Among the given options,<strong> hysteroscopy with laparoscopy</strong> is used to confirm the diagnosis.&nbsp;</p>\n<div class=\"page\" title=\"Page 115\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>For infertility evaluation, hysteroscopy and laparoscopy can detect m&uuml;llerian anomalies, screen for co-existent endometriosis, and exclude other tubal or uterine cavity pathology.</p>\n<p>This approach can differentiate between a septate and a bicornuate uterus. On laparoscopy, the presence of a uterine fundus indicates that the uterus is septate, while its absence indicates it is bicornuate. The capacity of each horn in a bicornuate uterus and the depth and thickness of the uterine septum prior to surgical resection can also be assessed.&nbsp;</p>\n<div class=\"page\" title=\"Page 445\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>MRI</strong>&nbsp;is the <strong>gold standard investigation</strong> for the diagnosis of Mullerian anomalies. It clearly delineates both the internal and external uterine anatomy. Complex anomalies and common associations like renal or skeletal anomalies can also be evaluated. It is also<strong> less invasive</strong> than hysteroscopy and laparoscopy in diagnosing Mullerian anomalies.</p>\n</div>\n</div>\n</div>\n</div>\n<p>Other options:</p>\n<p>Option A: <strong>Hysterosalpingography (HSG)</strong> provides information about the interior contour of the uterine cavity but <strong>cannot accurately visualize the external contour</strong> of the uterus.&nbsp;</p>\n<p>Option C: <strong>Laparoscopy alone</strong> as a diagnostic procedure <strong>cannot visualize the interior contour</strong> of a hollow viscus like the uterus. This can be done only with the help of hysteroscopy or imaging such as sonography, HSG, or MRI.</p>\n<div class=\"page\" title=\"Page 116\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Option D: <strong>Transvaginal sonography</strong> is used for the <strong>initial detection</strong> of uterine anomalies causing infertility or spontaneous abortions. <strong>Complete evaluation</strong> of these anomalies is done by <strong>MRI.</strong></p>\n<p>Note:&nbsp;</p>\n<ul>\n<li>Hysteroscopy is the <strong>gold standard investigation</strong> to <strong>visualize the uterine cavity</strong> and<strong> tubal ostia</strong>. It also has therapeutic benefits in cases of endometrial polyps, submucous resection of myoma, hysteroscopic adhesiolysis, and resection of uterine septum.&nbsp;</li>\n<li>Laparoscopy is the <strong>gold standard investigation</strong> to <strong>evaluate tubal factors</strong> of infertility.&nbsp;</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Mullerian Anomalies</h3><div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p class=\"ng-binding\">&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Class</strong></td>\n<td><strong>Mullerian anomaly</strong></td>\n<td><strong>Reason/Feature</strong></td>\n<td><strong>Treatment</strong></td>\n<td><strong>Complications</strong></td>\n</tr>\n<tr>\n<td>I</td>\n<td><strong>Uterine hypoplasia or uterine agenesis</strong></td>\n<td>Underdeveloped or non-developed paramesonephric duct</td>\n<td>\n<ul>\n<li>Infertility treatment -surrogacy&nbsp;</li>\n<li>Vaginoplasty for vaginal hypoplasia</li>\n</ul>\n</td>\n<td>Infertility\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>II</td>\n<td><strong>Unicornuate uterus</strong></td>\n<td>Non-developed paramesonephric duct</td>\n<td>Excision of&nbsp;rudimentary horn, if any &nbsp;</td>\n<td>\n<ul>\n<li>Uterine rupture</li>\n<li>Abortions</li>\n<li>Risk of miscarriage,</li>\n<li>Malpresentation&nbsp;</li>\n<li>Preterm delivery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>III</td>\n<td><strong>Uterus didelphys</strong></td>\n<td>Unfused paramesonephric duct</td>\n<td>\n<p>Metroplasty- Resection of membrane and fundal recombination. This can be:</p>\n<ul>\n<li>Hysteroscopic</li>\n<li>Open e.g., Strassman metroplasty</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Risk of miscarriage,</li>\n<li>Malpresentation&nbsp;</li>\n<li>Preterm delivery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>IV</td>\n<td><strong>Bicornuate uterus&nbsp;</strong></td>\n<td>Lower part is fused whereas upper part is unfused</td>\n<td>Metroplasty in selected cases&nbsp;</td>\n<td>\n<ul>\n<li>Risk of miscarriage,</li>\n<li>Malpresentation&nbsp;</li>\n<li>Preterm delivery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>V</td>\n<td><strong>Septate uterus&nbsp;</strong></td>\n<td>Septa of fused part persists</td>\n<td>Hysteroscopic septal resection&nbsp;</td>\n<td>\n<ul>\n<li>Infertility</li>\n<li>Risk of miscarriage,</li>\n<li>Malpresentation&nbsp;</li>\n<li>Preterm delivery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>VI</td>\n<td><strong>Arcuate uterus</strong></td>\n<td>A small indentation at upper part</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>VII</td>\n<td><strong>Diethylstillbesterone (DES), drug related</strong></td>\n<td>T-shaped uterus, shortened and narrow fallopian tubes, cervical collars (Cockscomb cervix)</td>\n<td>&nbsp;</td>\n<td>\n<ul>\n<li>Ectopic pregnancy</li>\n<li>Cervical incompetence</li>\n<li>Clear cell adenocarcinoma of cervix and vagina</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>A common complication is an abortion in the second trimester.</p>\n<p>Arcuate uterus: Some studies report no increase in adverse outcomes, whereas some studies have shown excessive second trimester loss, preterm labor and malpresentations.</p>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b5daabaa46584f8ca9566b45a6d7c54dx1280x4923.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1258",
      "difficulty": "medium"
    },
    {
      "text": "A 26-year-old pregnant woman, on examination was found to have infra-umbilical flattening. The fetal heart sounds were heard over the lateral side. What could be the fetal presentation/position?",
      "choices": [
        {
          "id": 1,
          "text": "Brow"
        },
        {
          "id": 2,
          "text": "Knee"
        },
        {
          "id": 3,
          "text": "Occipitoposterior"
        },
        {
          "id": 4,
          "text": "Right dorso-anterior"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The presence of infra-umbilical flattening and fetal heart sounds on the lateral side indicates that the fetus is in the <strong>occipito-posterior position.</strong></p>\n<div class=\"page\" title=\"Page 447\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Occipito-posterior (OP) position of the fetus is when the <strong>occiput</strong> is situated<strong> posteriorly</strong> over the <strong>sacroiliac joint</strong>, or directly over the sacrum. The fetus is in vertex presentation.</p>\n<p>Examination findings of OP position:</p>\n<ul>\n<li>On inspection, the abdomen appears flattened below the umbilicus (<strong>infra-umbilical flattening</strong>).</li>\n<li>Pelvic grips:\n<ul>\n<li>The head is <strong>not engaged.</strong></li>\n<li>The sinciput (cephalic prominence) is not prominently felt.</li>\n</ul>\n</li>\n<li>Auscultation: <strong>Fetal heart sounds</strong> are heard maximally over the <strong>flanks</strong>. However, in the direct OP position, they are heard in the midline.</li>\n</ul>\n<p>There are three variants of OP position:</p>\n<ul>\n<li><strong>Left OP</strong> position (<strong>fourth position</strong> of the vertex) - When the occiput points towards the <strong>left sacroiliac joint</strong>.&nbsp;</li>\n<li><strong>Right OP</strong> position (<strong>third position</strong> of the vertex) - When the occiput points towards the <strong>right sacroiliac joint</strong>. It is <strong>more common</strong> than the left OP position.</li>\n<li><strong>Direct OP position </strong>-<strong>&nbsp;</strong>When the occiput points directly towards the <strong>sacrum</strong>.</li>\n</ul>\n<p>All three positions may be primary (present before the onset of labor) or secondary (develops after the onset of labor).&nbsp;</p>\n<p>Other options:</p>\n<p>Option A: <strong>Brow presentation</strong> is a rare type of cephalic presentation where the position of the head is&nbsp;<strong>in between full flexion and full extension</strong>. The part of the head between the orbital ridge and the anterior fontanel presents at the pelvic inlet.</p>\n<p>Option B: <strong>Knee presentation</strong> is a type of <strong>breech</strong> presentation. Here, the thighs are extended but the knees are flexed, presenting at the pelvic inlet. The head will be palpable as a hard globular mass at the fundus.</p>\n<p>Option D:<strong> Right dorso-anterior position&nbsp;</strong>is when the fetal <strong>back</strong> is directed <strong>anteriorly</strong>. This occurs in a <strong>transverse lie</strong>. On examination, the abdomen appears wide, and a hard plane of resistance is felt. The fundus extends just above the umbilicus. The head is felt in one iliac fossa and the breech is felt in the other.</p>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/29d67545252146a8949df0d44d5f79aax1200x1907.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/64620fdac8fd4547ab70956b7f88a61cx1280x2337.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1206",
      "difficulty": "medium"
    },
    {
      "text": "A primi at term presented with labor pain and multiple painful vesicular lesions on her vulva. No rashes were found on other parts of the body. What will be the management of this case?",
      "choices": [
        {
          "id": 1,
          "text": "Acyclovir and elective Cesarean section"
        },
        {
          "id": 2,
          "text": "Acyclovir and induction of labor"
        },
        {
          "id": 3,
          "text": "Spontaneous delivery"
        },
        {
          "id": 4,
          "text": "Antiviral and normal vaginal delivery"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario of a primi in labor pain with multiple, painful vesicular lesions on her vulva is suggestive of an <strong>active herpes simplex virus</strong> (HSV) <strong>infection</strong>. Management involves the administration of acyclovir and elective cesarean section.</p>\n<p>HSV infection in pregnancy can be caused by either HSV-1 or HSV-2 and transmitted by sexual contact. The infection can be primary, nonprimary, first episode, and recurrent.&nbsp;&nbsp;</p>\n<p>HSV infection (both HSV 1 and 2) during pregnancy has a risk of vertical transmission of the infection to the fetus. The risk is higher in the primary than in the recurrent infection. The maximum risk of fetal infection is during labor, although it can occur in utero and post-natally from direct contact.&nbsp;</p>\n<p>Suspicious lesions should be sent for PCR testing or culture. Antiviral treatment with acyclovir should be given if found positive. Women with no active genital lesions, asymptomatic, or those with active lesions in non-genital areas can undergo normal labor and delivery.&nbsp;</p>\n<p>Management of HSV infection during pregnancy:</p>\n<ul>\n<li>Oral acyclovir or valacyclovir for primary or recurrent infections during pregnancy.</li>\n<li>IV acyclovir followed by oral acyclovir for severe or disseminated infection</li>\n<li>Oral analgesics or topical anesthetics for pain relief</li>\n<li>Catheterization for urinary retention</li>\n</ul>\n<p>Cesarean delivery reduces the risk of vertical transmission during labor and is indicated in:</p>\n<ul>\n<li>Cases of active genital lesions - both primary and recurrent</li>\n<li>Prodromal symptoms like vulval itching or burning</li>\n</ul>\n<p>Other options:</p>\n<p>Option B: The presene of active lesions is a contraindication for induction of labor.</p>\n<p>Option C: Spontaneous delivery is contraindicated in the presence of active lesions.</p>\n<p>Option D: Even after treatment with acyclovir, normal delivery is not indicated owing to the risk of dormant viral transmission to the fetus.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1202",
      "difficulty": "easy"
    },
    {
      "text": "A 30-year-old married woman came for an infertility evaluation. On performing further investigations, intramural fibroids of sizes 7x5cm and 5x3cm were seen at the right and left cornual ends of the uterus. Her husband's semen analysis was found to be normal. What is the appropriate management of this case?",
      "choices": [
        {
          "id": 1,
          "text": "Uterine artery embolization"
        },
        {
          "id": 2,
          "text": "Myomectomy"
        },
        {
          "id": 3,
          "text": "Artificial reproductive techniques"
        },
        {
          "id": 4,
          "text": "GnRH analogues"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The most appropriate management for a woman with infertility due to intramural fibroids at both the cornual ends of the uterus is&nbsp;<strong>myomectomy.</strong> The infertility, in this case, is due to the fibroids blocking the right and left cornua of the uterus.</p>\n<p><strong>Myomectomy</strong> refers to the removal of fibroids and preserving the uterus. It is indicated in women presenting with infertility, those who desire pregnancy, or those who wish to retain the uterus.</p>\n<p>Intracavitary fibroids can be resected via the hysteroscopic approach, while subserosal or intramural fibroids require laparotomy or laparoscopic myomectomy.</p>\n<p>Other options:</p>\n<p>Option A: Uterine artery embolization is not done in this case, as it may <strong>decrease fertility</strong>, as a result of pelvic adhesions. It is a technique in which polyvinyl alcohol (PVA), gel foam particles, or metal coils are injected into the uterine arteries. This embolization reduces vascularity and the size of the fibroid. It is best suited to <strong>control menorrhagia in multiparous women.</strong></p>\n<p>Option C:&nbsp;Artificial reproductive techniques are not indicated in this case as infertility is seen to be due to the fibroids blocking the cornual ends of the uterus. However, it may be considered at a later stage.</p>\n<p>Option D: GnRH analogs when used for 6 months, can reduce the tumor size by targeting the growth effects of estrogen and progesterone. It can be used in women with infertility caused by <strong>cornual fibroids</strong>. They are often used <strong>preoperatively</strong> to <strong>reduce the size</strong> of the fibroid and facilitate a hysteroscopic approach to surgery. However, it is <strong>expensive</strong> and can cause <strong>menopausal symptoms</strong> if used for<strong> &gt;6 months</strong>. Fibroids are known to <strong>regrow 3-4 months after stopping the therapy.&nbsp;</strong></p><hr><h3>Related Pearl: Myomectomy</h3><p id=\"H20\" class=\"headingAnchor\"><strong>Myomectomy</strong></p>\n<ul>\n<li class=\"headingAnchor\">Retains uterus and hence preserves childbearing function.</li>\n<li class=\"headingAnchor\">Effective for heavy menstrual bleeding and pelvic pressure.</li>\n<li class=\"headingAnchor\">Disadvantage - formation of new clones of abnormal myocytes.</li>\n<li class=\"headingAnchor\">Hysteroscopic myomectomy is the procedure of choice for removing intracavitary myomas.</li>\n<li class=\"headingAnchor\">Vaginal myomectomy is performed in case, a fibroid prolapses through the cervix.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d85871d192c5435dbc5db9d643e91318x1280x1022.7362482369534.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/05d580070ec34ee58874c527717369c3x1280x874.6967559943582.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6e46c219eb494439a07cb1d7cdaff0a1x1280x919.8307475317348.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Indications for treatment in an asymptomatic fibroid</h3><ul>\n<li>Infertility caused by a cornual fibroid blocking the tube, or a submucous fibroid causing habitual abortions.</li>\n<li>Any fibroid of more than 12 weeks size</li>\n<li>A pedunculated fibroid which can undergo torsion</li>\n<li>A fibroid causing pressure on the ureter/ bladder, leaving residual urine and causing a urinary infection.</li>\n<li>Rapidly growing fibromyoma in a menopausal woman implying impending malignancy</li>\n<li>When the nature of the tumor cannot be ascertained clinically (laparotomy is needed on this occasion).</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1211",
      "difficulty": "easy"
    },
    {
      "text": "A 28-year-old married woman who is anxious to conceive presents with copious vaginal discharge, without any itching. Her last menstrual period was 13 days ago. What is the cause of her vaginal discharge?",
      "choices": [
        {
          "id": 1,
          "text": "Candidiasis"
        },
        {
          "id": 2,
          "text": "Bacterial vaginosis"
        },
        {
          "id": 3,
          "text": "Trichomoniasis"
        },
        {
          "id": 4,
          "text": "Physiological"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical scenario of a young woman with copious, non-pruritic (without itching) vaginal discharge occurring 13 days after menstrual period (period of ovulation) is most likely to be leucorrhoea <strong>(physiological).</strong></p>\n<div class=\"page\" title=\"Page 395\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 395\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The term <strong>leucorrhoea</strong> can be used in conditions where normal vaginal secretion is increased in amount. An increase in this normal vaginal secretion develops physiologically:</p>\n</div>\n</div>\n</div>\n<ul>\n<li>At puberty</li>\n<li>At ovulation</li>\n<li>During pregnancy</li>\n<li>During the premenstrual phase, occasionally</li>\n</ul>\n<p>It may be cervical or vaginal in origin. A speculum examination of the vagina can distinguish between the two. If the discharge is cervical in origin, an excessive mucoid discharge will be visible at the external os.</p>\n<p>Normal discharge appears clear or white, without any odor or itching, and will have a pH of 3.8-4.2.</p>\n<p>Other options:</p>\n<p>Option A: Candidiasis is caused by infection with <strong>Candida albicans</strong> and presents with <strong>pruritus</strong>, burning, and dysuria with vulvar erythema, edema, and excoriations. A&nbsp;<strong>curdy white discharge </strong>will be present.&nbsp;</p>\n<p>Option B:&nbsp;<strong>Bacterial vaginosis</strong>&nbsp;is caused by an alteration in the normal vaginal flora and presents&nbsp;<strong>without</strong>&nbsp;<strong>itching</strong> and a malodorous grey-white discharge. It is diagnosed using <strong>Amsel's criteria</strong>, where&nbsp;at&nbsp;least three&nbsp;of the four following criteria should be present to confirm the diagnosis:</p>\n<ul>\n<li>Homogenous vaginal discharge</li>\n<li>Vaginal pH &gt; 4.5</li>\n<li>Amine-like odor on adding KOH (Whiff test positive)</li>\n<li>Clue cells (&gt;20% of cells)</li>\n</ul>\n<p>Option C:&nbsp;<strong>Trichomoniasis</strong>&nbsp;is caused by Trichomonas vaginalis and presents with a <strong>copious</strong>, frothy, <strong>offensive yellow-green discharge</strong> with <strong>vaginal soreness or irritation</strong> and urinary frequency. On examination, the&nbsp;vagina looks red and inflamed. The inflamed&nbsp;cervix <strong>looks like a strawberry</strong>&nbsp;with punctate hemorrhagic spots.</p>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Vaginal infections</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Bacterial vaginosis</strong></td>\n<td><strong>Trichomonas vaginitis</strong></td>\n<td>\n<p><strong>Candidal vaginitis</strong></p>\n</td>\n</tr>\n<tr>\n<td>Causative organism&nbsp;</td>\n<td>Altered vaginal flora- increased concentration of <strong><em>Gardnerella vaginalis</em></strong></td>\n<td><strong><em>Trichomonas vaginalis</em></strong></td>\n<td><strong><em>Candida albicans</em></strong></td>\n</tr>\n<tr>\n<td>Aetiology</td>\n<td>Increased vaginal pH</td>\n<td>Sexually transmitted</td>\n<td>Decreased immunity</td>\n</tr>\n<tr>\n<td>Sexual transmission</td>\n<td>No</td>\n<td>Yes</td>\n<td>No</td>\n</tr>\n<tr>\n<td>Discharge</td>\n<td>Fishy, thin, yellow</td>\n<td>Frothy, green</td>\n<td>Curdy, white</td>\n</tr>\n<tr>\n<td>Symptoms</td>\n<td>Fishy odour, no itching</td>\n<td>Itching and burning</td>\n<td>Itching, burning</td>\n</tr>\n<tr>\n<td>pH</td>\n<td>&gt;4.5</td>\n<td>&gt;4.5</td>\n<td>&lt;4.5</td>\n</tr>\n<tr>\n<td>Speculum</td>\n<td>No vaginal epithelium inflammation</td>\n<td>Strawberry cervix</td>\n<td>Inflamed-epithelium</td>\n</tr>\n<tr>\n<td>KOH</td>\n<td>Positive Whiff test</td>\n<td>The whiff test can be positive.</td>\n<td>Pseudohyphae seen.</td>\n</tr>\n<tr>\n<td>Wet mount</td>\n<td>Clue cells. No WBCs seen</td>\n<td>Motile trichomaonads, WBCs seen</td>\n<td>WBCs seen</td>\n</tr>\n<tr>\n<td>Treatment</td>\n<td>Metronidazole or Clindamycin</td>\n<td>Metronidazole, treat&nbsp;partner also</td>\n<td>Oral or vaginal azole, no need to treat partner.</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1210",
      "difficulty": "medium"
    },
    {
      "text": "A patient developed atonic postpartum hemorrhage after a normal vaginal delivery. She was shifted to the OT and the obstetrician planned ligation of vessels to arrest the bleeding. What is the order of ligation of the blood vessels supplying the uterus?",
      "choices": [
        {
          "id": 1,
          "text": "Uterine artery - Ovarian artery - Internal iliac artery"
        },
        {
          "id": 2,
          "text": "Uterine artery - Ovarian artery- External iliac artery"
        },
        {
          "id": 3,
          "text": "Uterine artery - Ovarian artery - Vaginal artery"
        },
        {
          "id": 4,
          "text": "Uterine artery - pudendal artery - Vaginal artery"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The order of ligation of vessels to arrest bleeding in atonic postpartum hemorrhage (PPH) is the <strong>uterine artery - ovarian artery - internal iliac artery</strong>.</p>\n<p>The ascending branch of the <strong>uterine artery </strong>is ligated between the upper and lower segments of the uterus, at the lateral border. If the bleeding continues, the <strong>ovarian and uterine artery anastomosis </strong>is ligated just below the ovarian ligament. If the bleeding still persists, the anterior division of the <strong>internal iliac artery </strong>is ligated 5 cm distal to the common iliac bifurcation. &nbsp;</p>\n<p>Unilateral or bilateral ligation of the internal iliac artery ligation causes a reduction in the pulse pres&shy;sure in the arteries distal to the ligation. This increases the chances of hemostasis via pressure and clot formation.</p>\n<div class=\"page\" title=\"Page 808\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Surgical methods to control PPH are outlined as stepwise uterine devascularization procedures:</p>\n<ul>\n<li>Compression sutures: B-Lynch suture</li>\n<li>Ligation of uterine arteries</li>\n<li>Ligation of ovarian and uterine anastomosis</li>\n<li>Ligation of internal iliac artery</li>\n<li>Angiographic embolization of the bleeding vessel</li>\n</ul>\n<p>Pelvic packing (usually done prior to embolization) and hysterectomy are other surgical methods employed to control PPH.</p>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e2720674c69b418e8fc02346abbcc09bx1280x2569.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1246",
      "difficulty": "easy"
    },
    {
      "text": "A teenage patient presented with a history of dysmenorrhea and chronic pelvic pain. On ultrasonography, a transverse vaginal septum was seen. What is the most common complication that can be seen in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Endometriosis"
        },
        {
          "id": 2,
          "text": "Tubo-ovarian abscess"
        },
        {
          "id": 3,
          "text": "Dermoid cyst"
        },
        {
          "id": 4,
          "text": "Theca lutein cyst"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The most common complication that can be seen in this patient is <strong>endometriosis</strong>.</p>\n<p>Transverse vaginal septum leads to obstructed flow of menstrual blood. This may lead to <strong>retrograde menstruation</strong>, which increases the likelihood of the development of <strong>endometriosis</strong>, according to Sampson's theory of endometriosis.</p>\n<p><strong>Transverse vaginal septum</strong> occurs as a result of the <strong>failure of Müllerian duct fusion</strong> or <strong>failure of vaginal plate canalization</strong>. It may be obstructive or non-obstructive. The commonest site of a transverse septum is the junction between the upper and middle third of the vagina.</p>\n<p>Patients with an obstructive or imperforate vaginal septum present with symptoms similar to the imperforate hymen. Symptoms include <strong>amenorrhoea</strong>, <strong>cyclical abdominal pain</strong>, urinary symptoms, and a palpable pelvic mass. The <strong>vagina</strong> may appear <strong>shortened</strong> and the cervix may not be identifiable. Secondary sexual characteristics appear normal. The diagnosis can be confirmed with ultrasound or MRI.</p>\n<p>There is an increased<strong> risk of endometriosis.</strong> Other complications such as <strong>pyomucocolpos, pyometra</strong>, and <strong>pyosalpinges</strong> can also develop in infants with obstructive vaginal septums. </p>\n<p>Treatment is by manual dilatation of the perforation or surgical excision of the septum. </p>\n<p>Other options:</p>\n<p>Option B: <strong>Tubo-ovarian abscess</strong> develops in pelvic inflammatory disease.</p>\n<p>Option C: <strong>Dermoid cysts</strong> are cystic ovarian tumors that are often associated with mucinous cystadenomas.</p>\n<p>Option D: <strong>Theca lutein cysts</strong> are found in association with hydatidiform moles, choriocarcinoma, and gonadotropin or clomiphene citrate therapy. They regress with the management of the mole and choriocarcinoma and discontinuation of gonadotropin therapy.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1244",
      "difficulty": "easy"
    },
    {
      "text": "A 28-year old pregnant woman came for a routine antenatal check-up in her second trimester. Four years back, she delivered 2 healthy full-term twins. What would her obstetric score be?",
      "choices": [
        {
          "id": 1,
          "text": "G2P2"
        },
        {
          "id": 2,
          "text": "G3P2"
        },
        {
          "id": 3,
          "text": "G2P1"
        },
        {
          "id": 4,
          "text": "G3P1"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The obstetric score of a pregnant woman who previously delivered twins would be <strong>G2P1</strong><strong>&nbsp;(gravida 2 para 1).</strong></p>\n<p>The term&nbsp;<strong>gravida</strong>&nbsp;refers to the <strong>number of times</strong> the woman has been <strong>pregnant</strong>, irrespective of whether it crossed the period of viability. The<strong>&nbsp;current pregnancy</strong>&nbsp;is<strong>&nbsp;included&nbsp;</strong>in this count. Since she has been pregnant once before with twins and is currently pregnant now, gravida will be 2.</p>\n<p>The term<strong> para </strong>refers to&nbsp;the <strong>number of previous pregnancies</strong>&nbsp;<strong>reaching </strong>a period of<strong> viability </strong>(gestation of <strong>28 weeks</strong>). It does not increase to a higher number if multiples (twins/triplets) are delivered in a given pregnancy and still count as one birth. A<strong>&nbsp;current pregnancy</strong>, if any, is<strong>&nbsp;not included&nbsp;</strong>in this count. Therefore, para here will be 1 since she had one birth of twins and the present pregnancy is not counted.</p>\n<p>Both gravidity and parity refer to the pregnancies and not the fetuses.</p>\n<p>Note: The <strong>period of viability</strong> is when the fetus is capable of independent existence. The <strong>WHO</strong> defines it to be <strong>24 weeks</strong> while the <strong>Indian definition</strong> is <strong>28 weeks</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1209",
      "difficulty": "easy"
    },
    {
      "text": "A 27-year-old woman who is on oral contraceptive pills for contraception has forgotten to take her pills on 4 different days in the last 2 weeks. She presents to the primary health center, asking for advice. What would you suggest to her?",
      "choices": [
        {
          "id": 1,
          "text": "Take 4 pills now, continue the schedule, use barrier method of contraception"
        },
        {
          "id": 2,
          "text": "Take 1 pill now, continue the schedule, and use barrier method of contraception"
        },
        {
          "id": 3,
          "text": "Take 1 pill now, use barrier method, and consider emergency contraception in case of recent intercourse"
        },
        {
          "id": 4,
          "text": "Discard the pack, start a new pack with alternate method of contraception"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>A woman who has missed 4 oral contraceptive pills in the last two weeks should <strong>take one hormonal pill </strong>as soon as possible and <strong>finish all hormonal pills</strong> in the pack as scheduled, <strong>throw away the 7 non-hormonal pills</strong> in a 28-pill pack and <strong>start a new pack the next day</strong>. </p>\n<table>\n<tbody>\n<tr>\n<td><strong>Missed pills</strong></td>\n<td><strong>Management</strong></td>\n</tr>\n<tr>\n<td>\n<p>Missed 1 or 2 pills/ started new pack 1 or 2 days late?</p>\n<p> </p>\n</td>\n<td>\n<p>You have two options: take one hormonal pill right away, or take two pills at your usual scheduled time. </p>\n<p>The risk of pregnancy is minimal to none.</p>\n<p> </p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Missed 3 or more pills in the first or second week/started new pack 3 or more days late?</p>\n</td>\n<td>\n<p>Take one hormonal pill immediately and then continue taking your pills as scheduled. </p>\n<p>Make sure to use a backup method of contraception for the next seven days.</p>\n<p>Additionally, if you've had sexual intercourse within the last 72 hours, consider taking emergency contraceptive pills.</p>\n<p> </p>\n</td>\n</tr>\n<tr>\n<td>Missed 3 or more pills in the third week?</td>\n<td>\n<p>Take one hormonal pill as soon as you can and complete the entire pack of hormonal pills according to the schedule. </p>\n<p>Discard the seven non-hormonal pills in a 28-pill pack. </p>\n<p>Begin a new pack the following day.</p>\n<p> </p>\n</td>\n</tr>\n<tr>\n<td>Missed any nonhormonal pills? (last 7 pills in 28-pill pack)</td>\n<td>\n<p>Dispose of any missed non-hormonal pills. </p>\n<p>Continue taking your combination oral contraceptives (COCs), one pill each day. </p>\n<p>Begin the new pack as you normally would.</p>\n<p> </p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>If any non-hormonal pills were missed, she can discard the remaining pills. Start the new pack of oral contraceptives and continue taking as usual.</p>\n<p>If she vomits within 2 hours of taking a pill, another pill from the pack should be taken as soon as possible. After that, continue taking the pills as scheduled. If the vomiting or diarrhea persists for &gt;2 days, follow the instructions for 1 or 2 missed pills as mentioned above.</p>\n<p>The contraceptive method should be discontinued and changed in the following situations:</p>\n<ul>\n<li>Unexplained or prolonged heavy vaginal bleeding that suggests an underlying condition not related to the method</li>\n<li>Starting anticonvulsant medication or treatment with rifampicin</li>\n<li>Migraines</li>\n<li>Non-ambulatory conditions lasting for &gt;1 week like major surgery, leg in a cast, etc. Combined oral contraceptives can be restarted 2 weeks after ambulation.</li>\n<li>Suspected heart or liver disease, hypertension, deep vein thrombosis, stroke, breast cancer, diabetes, or gall bladder disease </li>\n</ul>\n<p> </p>\n<p> </p><p><strong>Note:</strong> Since this is a recall question and it can not be edited. The closest option currently out of the four options is the 4th option.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1239",
      "difficulty": "medium"
    },
    {
      "text": "A 30-year-old female patient, on treatment for infertility, came with 6 weeks of amenorrhea, abdominal pain, and mild vaginal bleeding. Her beta hCG level was 2800 mIU/mL. On ultrasound, a 3cm mass was seen in the left adnexa. It contained a gestational sac with no fetal cardiac activity. What is the most appropriate management for this patient?<div class='question-desc-html'><p>hCG- Human chorionic gonadotropin&nbsp;</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Expectant management"
        },
        {
          "id": 2,
          "text": "Single dose methotrexate"
        },
        {
          "id": 3,
          "text": "Salpingectomy"
        },
        {
          "id": 4,
          "text": "Milking of the tube"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>A patient on infertility treatment, with 6 weeks of amenorrhea, abdominal pain, and vaginal bleeding with beta hCG levels of 2800 mIU/mL, and a gestational sac in the left adnexa points to the diagnosis of <strong>unruptured ectopic pregnancy </strong>and the most appropriate management is single-dose methotrexate.</p>\n<p>A pregnancy is considered ectopic if implantation occurs at a site outside the uterine cavity. The majority of ectopic pregnancies occur in the fallopian tube, the <strong>ampulla</strong> being the<strong> most common site</strong>.</p>\n<p>Management of ectopic pregnancy:&nbsp;</p>\n<p><strong>Expectant</strong> management: Ectopic pregnancies measuring <strong>&lt;3 cm</strong> and with <strong>declining beta hCG </strong>levels initially&nbsp;<strong>&lt;1500 mIU/mL</strong> may resolve without inter&shy;vention and can be managed expectantly.&nbsp;</p>\n<p><strong>Medical</strong> <strong>management</strong> with <strong>single</strong> or<strong> multiple-dose methotrexate</strong> is preferred if:</p>\n<ul>\n<li>Hemodynamic stability</li>\n<li>Serum beta-hCG <strong>&ge;1500 mIU/ml </strong>and <strong>&le;5000 mIU/mL</strong></li>\n<li>Mean sac diameter<strong> &lt;3.5cm</strong> with <strong>no fetal cardiac activity</strong> detected on transvaginal ultrasound.</li>\n<li>Patients are willing and able to comply with post-treatment follow-up and have access to emergency medical services within a reasonable time frame in case of a deterioration in the clinical status.</li>\n</ul>\n<p>Methotrexate(MTX) can be given as a single IM dose of 50 mg/m<sup>2</sup> or as a multiple-dose regimen of 1mg/kg on days 1, 3, 5, and 7.</p>\n<p><strong>Surgical management</strong> with <strong>salpingectomy</strong> or <strong>salpingostomy</strong> is done when:</p>\n<ul>\n<li>Criteria for expectant and medical management are not met</li>\n<li>Gestational sac&nbsp;<strong>&gt;3.5 cm</strong></li>\n<li>Fetal cardiac activity present</li>\n<li><strong>Beta hCG &gt; 5000 mIU/mL</strong></li>\n<li>Significant pain and hemoperitoneum&nbsp;</li>\n<li>Failure of expectant or medical management</li>\n<li>Clinical status of patient warrants urgent intervention</li>\n<li>Doubtful compliance with medical management&nbsp;</li>\n</ul>\n<p><strong>Milking</strong> of the tube through the fimbriae carries a <strong>high risk of bleeding</strong>, <strong>damage to the tube</strong>, the <strong>persistence of trophoblastic tissue,</strong> and <strong>recurrence</strong> of ectopic pregnancy.&nbsp;</p>\n<p>&nbsp;</p><hr><h3>Related Pearl: Beta hCG in pregnancy</h3><p><strong>The pattern of beta hCG :</strong></p>\n<div class=\"page\" title=\"Page 122\">First detectable in plasma&nbsp;7 to 9 days post-LH surge</div>\n<div class=\"page\" title=\"Page 122\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &dArr;</div>\n<div class=\"page\" title=\"Page 122\">Doubles every 2 days</div>\n<div class=\"page\" title=\"Page 122\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &dArr;</div>\n<div class=\"page\" title=\"Page 122\">Peaks at 8 to 10 weeks of gestation(~<strong>100 IU/mL</strong>)</div>\n<div class=\"page\" title=\"Page 122\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &dArr;</div>\n<div class=\"page\" title=\"Page 122\">Begins to decline at&nbsp;10 to 12 weeks</div>\n<div class=\"page\" title=\"Page 122\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &dArr;</div>\n<div class=\"page\" title=\"Page 122\">Plateau at 16 weeks till term</div>\n<div class=\"page\" title=\"Page 122\">&nbsp;</div>\n<ul>\n<li class=\"page\" title=\"Page 122\">Higher maternal plasma hCG levels- Multifetal pregnancy, <strong>erythroblastosis fetalis</strong>, gestational trophoblastic disease, <strong>Down syndrome</strong>.</li>\n<li class=\"page\" title=\"Page 122\">Lower hCG plasma levels -early pregnancy wastage and ectopic pregnancy.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1259",
      "difficulty": "easy"
    },
    {
      "text": "A 30-year-old woman on oral contraceptives for the past 6 months presents with 6 weeks of amenorrhea. What would be the best method of assessing the gestational age of this patient?<div class='question-desc-html'><p>LMP- Last menstrual period</p>\n<p>USG- Ultrasonography</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Crown rump length by USG"
        },
        {
          "id": 2,
          "text": "Adding 280 days to the LMP"
        },
        {
          "id": 3,
          "text": "Fundus examination"
        },
        {
          "id": 4,
          "text": "Adding 256 days to the LMP"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The best method of assessing the gestational age of a patient on oral contraceptives with 6 weeks of amenorrhea is by measuring the <strong>crown-rump length (CRL)</strong> using ultrasonography.</p>\n<p>Gestational age refers to the duration of pregnancy calculated from the first day of the LMP. It is usually expressed in weeks. Following the use of oral contraceptives, ovulation may have been later than 2 weeks after the LMP. Therefore, <strong>gestational age</strong> calculated with the help of <strong>LMP</strong> will&nbsp;be <strong>inaccurate</strong>.</p>\n<p>First-trimester ultrasound measurement of CRL is the best method to assess gestational age. It is measured from the <strong>vertex to the coccyx</strong>.</p>\n<ul>\n<li>CRL (in mm) + 6.5 = gestational age in <strong>weeks</strong> (or)</li>\n<li>CRL (in mm) + 42 days = gestational age in <strong>days</strong>.</li>\n</ul>\n<p>CRL measurement is shown in the image below:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b715a494b85c410c82c45ec9bc851ad0x720x577.JPEG\" alt=\"Explanation Image\"><div class=\"page\" title=\"Page 70\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 70\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 757\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Ultrasonographic parameters for estimation of the gestational age according to the trimester are as follows:</p>\n</div>\n</div>\n</div>\n</div>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Trimester</strong></p>\n</td>\n<td>\n<p><strong>Parameter</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>1st&nbsp;</p>\n</td>\n<td>\n<p>Crown-rump length (CRL)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>2nd and 3rd&nbsp;</p>\n</td>\n<td>\n<ul>\n<li>Biparietal diameter (BPD)</li>\n<li>Abdominal Circumference (AC)</li>\n<li>Head Circumference (HC)</li>\n<li>Femur Length. (FL)&nbsp;</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<div class=\"page\" title=\"Page 70\">Other options:</div>\n<div class=\"page\" title=\"Page 70\">&nbsp;</div>\n<div class=\"page\" title=\"Page 70\">Option B: Adding 280 days to the LMP will provide the <strong>expected delivery date (EDD)</strong>. Adding 9 months + 7 days to the LMP or 280 days to the LMP is <strong>Naegele&rsquo;s formula</strong> for calculating the EDD.</div>\n<div class=\"page\" title=\"Page 70\">&nbsp;</div>\n<div class=\"page\" title=\"Page 70\">Option C: Measurement of <strong>fundal height</strong> in cm (with a variation of 1-2cm) is roughly equal to the <strong>gestational age</strong> in weeks, <strong>after 24 weeks of pregnancy</strong>. This is measured from the superior border of the symphysis pubis to the top of the uterine fundus when the bladder is empty.&nbsp;</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1222",
      "difficulty": "easy"
    }
  ]
}